Dbv Technologies is a biopharmaceutical company based in Montrouge, France, specializing in the development of innovative therapies for food allergies and other immunological conditions. The company focuses on its proprietary Viaskin technology, which utilizes a unique method of delivering biologics through the skin to enhance immune tolerance. With a commitment to advancing treatment options, Dbv Technologies aims to improve the quality of life for patients affected by severe allergies and related disorders.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

27 Patents

#12 in Montrouge

#788 in France

#24,034 in the World

Montrouge, France

Dbv Technologies

Forward Citations = 160

36 inventors:

Pierre-Henri Benhamou (14 out of 14 patents)

Bertrand Dupont (14 out of 14 patents)

Christophe Dupont (13 out of 13 patents)

4. Pascale Ehouarn (8 out of 8 patents)

5. Jérôme Villette (8 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dbv Technologies. Retrieved from https://idiyas.com/company/dbv-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

15 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]